Legal Headlines

BLOOD MESOMARK MESOSELIOMA TESTThe Food and Drug Administration (FDA) approved the MESOMARK test to help monitor treatment response in patients with malignant mesothelioma. MESOMARK test indicates the beginning of a new era in the monitoring of mesothelioma cancer, “said Dr. W. Jeffrey Allard, vice president and scientific director of Fujirebio Diagnostics.” As the first in vitro test for patients with aggressive disease will allow physicians to more accurately determine the recurrence and monitor treatment of patients. “The test MESOMARK test was developed to measure levels of a biomarker, mesothelin, in serum. Biomarkers are substances in concentrations higher than normal blood, urine or body tissues of patients with certain types of cancer. Test can be used to monitor patients confirming that the mesothelioma recurrence in patients after surgery, or for measuring response to therapies. “current diagnostic tests are not ideal for measuring changes in tumor volume , which is key to controlling the disease, “continued Allard.” Since the results MESOMARK * correlation with tumor volume, provides an indispensable tool to monitor the status of patients. And “our plan to collect more data in the future to support the use of the test to detect mesothelioma.”

MESOMARK test are now making it possible – with a simple blood test to monitor response to treatment and to detect recurrence after treatment. This provides a significant advantage to patients racing against this aggressive type of cancer. “Mesoamerica Foundation is the national research funding, patient support and advocacy organizations dedicated to eradicating mesothelioma is a deadly disease. Those who wish to participate in trials MESOMARK be asked to provide one or more samples blood. Then the blood samples sent to a national reference laboratory for testing. along with other clinical and laboratory data obtained by the medical decisions about their treatment and care, can be simplified. You may discontinue the test at any time.

LINK: Diagnisis mesothelioma